Each of us has held beliefs—obtained through observation, experience or even formal education—that were later found to be wrong. In fact, medical schooling begins with a warning: “Half of all that you will be taught will be proven false in the future, yet which half cannot be known at present!” Some recently “overturned” beliefs involve the human gut microbiome, beginning with its scope, its diversity and, currently, the various ways it affects and is affected by the body. Here is a review of what is known now and what is currently under investigation.
THE BIG PICTURE: THE HUMAN MICRO-BIOME
The human microbiome, as a whole, is the population of all microscopic life-forms that live and thrive within the human organism. Each area of our body—such as skin, ears, lungs or gut—has distinct microbial populations and diversity. Even within an organ, the microbiome can be unique to specific anatomical locations.
Today, the human microbiome is considered an organ system, revolutionizing our understanding of human health, disease and fitness (Baquero 2012). The human microbiome can easily and quickly be altered by an event or events like the introduction of antibiotics. This is, of course, also true of the subsets of this system, including the microbiome in the human gut.
FOCUSING IN: GUT MICRO-ORGANISMS
The dimensions of the gut microbiome are described in astronomical terms. The 100 trillion microbes of the gut microbiome vastly outnumber the human cell population of 37 trillion. By gene count, the multiple is greater, with 20,000 human genes and several million microbial genes (Sender, Fuchs & Milo 2016).
The human gut microbiome contains several types of microorganisms, including bacteria, viruses, protists, fungi, parasites and prions (Alberts et al. 2002). A limited number are known to be pathogens, or microorganisms that can cause disease. Often a select strain or subspecies will give rise to a specific disease; for example, the microbe Salmonella typhi causes typhoid fever. If a type of microorganism is known not to cause harm, it is labeled a commensal and, if beneficial, it is called a symbiont.
For many years, it was believed there were only several dozen species of microbes in the gut, largely because of the ways microorganisms were identified. Traditionally, methods involved adding a special stain to a sample or observing the growth of colonies on a medium such as blood agar.
When gene sequencing was introduced, it allowed identification of microbes by their DNA and RNA. Scientists soon realized that the species count of gut microbes was actually in the millions. (Thus, until all species of gut microbiota are identified and investigated, our attempts at manipulating the gut microbiome with probiotics and other measures may lead to unintended consequences.)
DNA sequencing also led to another discovery about the diversity of microbes in the human gut. For decades, the classification system of life on Earth has included several domains, further subdivided into kingdom, phylum, class, family, order, genus and species. Then, in the late 1970s, Carl Woese, PhD, at the University of Illinois, Urbana-Champaign, discovered the ancient domain archaea (Sapp & Fox 2013). For many years, archaea were believed to be bacteria, but when their DNA was sequenced, they were found to be more alien than any form of life yet discovered.
Archaea are extremophiles—microorganisms able to survive in extreme environments (Rampelotto 2013). They have been found living in rocks, ocean floor volcanic vents, boiling mineral springs and even outer space. In fact, the new science of astrobiology considers them a prime candidate for the first life on Earth, perhaps having arrived from another solar system. Interestingly, they are also found in the human gut microbiome.
Recently, some surprising discoveries were made regarding gene transfer, as well. The belief that genes could pass to the next generation only by vertical transmission (from parent to offspring) was overturned by Nobel laureate Barbara McClintock, PhD, who discovered “jumping genes” (Ravindran 2012). These genes allow horizontal transfer of genetic information—that is, between two different species!
HOW GENES AFFECT THE GUT
Microbiome genes are essential for human survival. Genes from the microbiome—as well as from one’s diet and environment—may be active, be horizontally transferred or act as epigenetic influencers (Carbonero 2017).
We are exposed to millions of genes and epigenetic factors from our diet, water and environment. Prebiotics, probiotics, synbiotics, diet, antibiotics, pharmaceuticals, toxins, sunlight, exercise, gender, air pollution, sleep, tobacco smoking, stress and other factors may influence gene expression and affect health and well-being (Conlon & Bird 2015; Kashtanova et al. 2016; Imhann et al. 2017; Allen et al. 2018; Clark & Mach 2017; Jašarević, Morrison & Bale 2016; Beamish, Osornio-Vargas & Wine 2011; Benedict et al. 2016; Reynolds et al. 2017; Lutgendorff, Akkermans & Söderholm 2008).
The biodiversity of food sources exposes the gut to millions of unique genes from tens of thousands of species and cultivars. Although there are concerns about ingesting genetically modified organisms (GMOs), they have been consumed for more than 10,000 years in various forms, from cross-bred cereal grains to livestock (Oliver 2014). Further, an international collaborative research program called the Human Genome Project discovered that 8% of the human genome is not of human origin and was horizontally transferred from ancient viruses, thus making humans fit the designation of GMOs. Additional research suggests that an even larger percentage of the human genome may have originated in other species (Horie et al. 2010).
THE IMPACT OF THE GUT ON THE BODY
There are several pathways of communication between the brain and gut, the most prominent being the vagus nerve (Breit et al. 2018). Of the active two-way communication, over 90% is from the gut to the brain (Bonaz, Bazin & Pellissier 2018). The gut microbiome houses some 70% of the immune system (Vighi et al. 2008) and communicates with the immune system, lymphatic system, endocrine system (hormones) and circulatory system. Metabolites, neurotransmitters, hormones, cytokines, electrical signals and inflammatory markers are generated by the gut microbiome itself—or from gastrointestinal cells influenced by it.
In the months and years to come, evidence-based science will identify specific strains of microbes as pathogens or symbionts, allowing therapeutic modification of the microbiome. Here are a few things currently known and under investigation.
Health conditions. Changes in the gut microbiome are associated with a variety of health conditions, including autism, arthritis, cancer, heart disease, depression and others. Therapeutic microbes are likely to be identified for obesity (Rouxinol-Dias et al. 2016), heart disease, diabetes (Zeevi et al. 2015; Sanz et al. 2018) and other common conditions, opening new approaches to prevention and management (Kuntz & Gilbert 2017; Thursby & Juge 2017).
Leaky gut syndrome. The gut microbiome affects the tight junctions that maintain the integrity of the gut barrier. When tight junctions are weakened, gaps between the cells of the intestinal lining may lead to “leaky gut syndrome,” which allows microbes, metabolites and toxins to pass from the digestive system into the bloodstream.
Mental health. Microbes that manufacture specific metabolites, hormones and neurotransmitters—such as serotonin, dopamine, acetylcholine or their precursors—may be utilized for mood disorders and are already described as psychobiotics (Sarkar et al. 2016; Bastiaanssen et al. 2018; Lach et al. 2018).
Obesity. The gut microbiome aids in the digestion of food. Calorie and nutrient absorption, glycemic index and energy regulation are dependent on more than the food consumed. These functions also depend on the diversity of the gut microbial population, with specific species and strains of microbes extracting more calories from foods than others, potentially contributing to obesity as well as type 2 diabetes and metabolic syndrome.
Metabolism. Some gut microbes may produce hormones similar to human hormones that regulate metabolism (such as DPP4-like activity). Others may modulate immune and metabolic function—for example, microbes may increase adiponectin levels in adipose tissue, increase AMPK activation in skeletal and adipose tissue, and alter ghrelin levels (Yanagi et al. 2017; Olivares et al. 2018).
Overall health. Exercise may express some of its benefits through the gut microbiome as well. And our circadian rhythm, which regulates sleep, both influences and is influenced by the gut microbiome.
THE END GOAL: DIVERSITY OF GUT MICROBIOTA
Scientific evidence supports the belief that the greater the diversity of the gut microbiome, the healthier the individual (Lozupone et al. 2012). Although this is not proven knowledge, working toward eliminating antibiotics (as well as artificial sweeteners and herbicides, which have antibiotic properties) from the food supply would seem logical, since antibiotics kill friendly gut bacteria as well harmful ones (Prashant et al. 2012). It would also seem prudent to encourage microbiome diversity through the consumption of a variety of fermented and gut-friendly foods, such as kimchi, yogurt and sauerkraut.
Unfortunately, the probiotic industry has a profit motive—of about $50 billion per year (Turner 2016)—to turn this logic on its head, encouraging the consumer to swallow a commercial product that contains billions of just one (or a few) microbial species—every day, indefinitely. Doing so, however, tends to support microbial uniformity of the gut, which is the opposite of the desired diversity. That said, the odds of the microbial species in a yogurt being exactly the ones that the gut microbiome needs for optimal health would be like winning the probiotic lottery.
Simply put, our health and well-being may be dependent on our microbiome diversity. Thus, when it comes to probiotics, we would be well served to follow the wisdom of the great 18th century Scottish enlightenment philosopher David Hume: “A wise man proportions his belief to the evidence.” It’s a small world after all—especially in the microbiome!